Development Level

Tbio 13 | 11,651
Tchem 4 | 1,388
Tdark 2 | 6,593

IMPC Phenotype

abnormal behavior 3 | 298
decreased lean body mass 2 | 135
decreased total body fat amoun... 2 | 207
increased lean body mass 2 | 172
abnormal bone mineralization 1 | 38
abnormal sleep behavior 1 | 70
decreased IgE level 1 | 6
decreased body length 1 | 101
decreased body weight 1 | 161
decreased bone mineral density 1 | 126
decreased caudal vertebrae num... 1 | 53
decreased circulating LDL chol... 1 | 38
decreased fasted circulating g... 1 | 65
decreased lumbar vertebrae num... 1 | 2
decreased mean corpuscular vol... 1 | 79
decreased prepulse inhibition 1 | 82
decreased sacral vertebrae num... 1 | 1
decreased startle reflex 1 | 75
hyperactivity 1 | 148
improved glucose tolerance 1 | 79
increased body length 1 | 32
increased bone mineral content 1 | 108
increased bone mineral density 1 | 72
increased circulating calcium ... 1 | 34
increased circulating triglyce... 1 | 42
increased fasted circulating g... 1 | 76
increased heart weight 1 | 62
increased lumbar vertebrae num... 1 | 1
increased mean corpuscular hem... 1 | 96
increased mean corpuscular vol... 1 | 92
increased sacral vertebrae num... 1 | 1
increased total body fat amoun... 1 | 134
increased vertical activity 1 | 24
preweaning lethality, complete... 1 | 979
preweaning lethality, incomple... 1 | 499
thrombocytopenia 1 | 56

Disease

Carcinoma 12 | 11,493
ovarian cancer 12 | 8,520
glioblastoma 10 | 5,792
psoriasis 9 | 6,694
group 3 medulloblastoma 8 | 4,104
medulloblastoma, large-cell 8 | 6,241
osteosarcoma 8 | 7,950
primitive neuroectodermal tumor 8 | 3,035
Cancer 7 | 2,499
atypical teratoid / rhabdoid tumor 7 | 5,112
lung cancer 7 | 4,740
ependymoma 6 | 4,679
malignant mesothelioma 6 | 3,232
adult high grade glioma 5 | 3,801
lung adenocarcinoma 5 | 2,716
Astrocytoma, Pilocytic 4 | 3,081
Bipolar Disorder 4 | 666
Breast cancer 4 | 3,578
Schizophrenia 4 | 1,160
colon cancer 4 | 1,478
invasive ductal carcinoma 4 | 2,951
ulcerative colitis 4 | 1,819
Endometriosis 3 | 540
Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 | 20
Myeloid Leukemia, Chronic 3 | 23
Waldenstrons macroglobulinemia 3 | 765
adrenocortical carcinoma 3 | 1,428
astrocytoma 3 | 1,146
autosomal dominant Emery-Dreifuss muscular dystrophy 3 | 510
ductal carcinoma in situ 3 | 1,745
hereditary spastic paraplegia 3 | 318
intraductal papillary-mucinous adenoma (IPMA) 3 | 2,955
intraductal papillary-mucinous carcinoma (IPMC) 3 | 2,989
intraductal papillary-mucinous neoplasm (IPMN) 3 | 3,291
non-small cell lung cancer 3 | 2,890
oligodendroglioma 3 | 2,850
spina bifida 3 | 1,074
subependymal giant cell astrocytoma 3 | 2,287
Adenocarcinoma Of Esophagus 2 | 14
Amyotrophic lateral sclerosis 2 | 451
Arsenic Poisoning 2 | 62
Arthritis, Juvenile 2 | 126
Breast Neoplasms 2 | 445
Carcinoma, Hepatocellular 2 | 228
Depressive disorder 2 | 409
Epilepsy 2 | 792
Juvenile arthritis 2 | 126
Liver Cirrhosis, Experimental 2 | 769
Liver Neoplasms, Experimental 2 | 59
Liver carcinoma 2 | 240
Male infertility 2 | 206
Mammary Neoplasms 2 | 425
Mental Depression 2 | 333
Multiple myeloma 2 | 1,332
Neoplasm Metastasis 2 | 168
Pleomorphic adenoma 2 | 18
Prostatic Neoplasms 2 | 495
Retinitis pigmentosa 59 2 | 11
Rheumatoid arthritis 2 | 1,191
Seasonal affective disorder 2 | 28
Sleep Disorders, Circadian Rhythm 2 | 5
Small Cell Lung Carcinoma 2 | 41
Small cell carcinoma of lung 2 | 45
active Crohn's disease 2 | 922
acute quadriplegic myopathy 2 | 1,158
aldosterone-producing adenoma 2 | 665
astrocytic glioma 2 | 2,597
breast carcinoma 2 | 1,638
cutaneous lupus erythematosus 2 | 1,057
diabetes mellitus 2 | 1,728
gastric carcinoma 2 | 807
group 4 medulloblastoma 2 | 1,855
hepatocellular carcinoma 2 | 547
inflammatory breast cancer 2 | 286
interstitial cystitis 2 | 2,312
juvenile dermatomyositis 2 | 1,187
medulloblastoma 2 | 720
nasopharyngeal carcinoma 2 | 1,058
pancreatic cancer 2 | 2,398
pediatric high grade glioma 2 | 1,064
pituitary cancer 2 | 1,972
primary pancreatic ductal adenocarcinoma 2 | 1,109
tuberculosis 2 | 2,010
urothelial carcinoma 2 | 318
Actinic keratosis 1 | 21
Adrenal Gland Neoplasms 1 | 11
Ameloblastoma 1 | 24
Balkan Nephropathy 1 | 6
Carotid Artery Diseases 1 | 11
DOID:8600 1 | 4
Gastrointestinal stromal tumor 1 | 62
In situ carcinoma 1 | 3
Intestinal benign neoplasm 1 | 12
Malignant neoplasm of skin 1 | 15
Malignant tumor of colon 1 | 19
Neurilemmoma 1 | 23
Peutz-Jeghers syndrome 1 | 21
Skin benign neoplasm 1 | 6
Tumors of Adrenal Cortex 1 | 3
Upper respiratory tract disease 1 | 15

Tissue

Blood and immune system 18 | 16,909
Cardiovascular System 18 | 15,192
Digestive Tract 18 | 17,369
Endocrine System 18 | 18,159
Female tissues 18 | 17,400
Liver and Pancreas 18 | 16,750
Male tissues 18 | 17,142
Nervous System 18 | 16,725
Respiratory system 18 | 16,393
Skin and soft tissues 18 | 17,230
Urinary Tract 18 | 16,678

Target Family

Non-IDG 9 | 12,091
Enzyme 4 | 4,145
Transcription Factor 4 | 1,400
Kinase 1 | 634
Nuclear Receptor 1 | 48

GO Process

entrainment of circadian clock... 19 | 19
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
F-box/LRR-repeat protein 3 FBXL3 Tbio Non-IDG -0.99438 10.2 174
F-box/LRR-repeat protein 21 FBXL21 Tdark Non-IDG 0.00000 0
RNA-binding protein 4 RBM4 Tbio Non-IDG -1.71130 51.9 162
Serine/threonine-protein phosphatase PP1-alpha catalytic subunit PPP1CA Tchem Enzyme -2.17010 139.0 378
Serine/threonine-protein phosphatase PP1-beta catalytic subunit PPP1CB Tbio Enzyme -1.55192 33.3 377
Protein PML PML Tbio Non-IDG -2.63785 373.8 470
Cellular tumor antigen p53 TP53 Tchem Transcription Factor -4.74112 54026.3 6298
Period circadian protein homolog 1 PER1 Tbio Non-IDG -1.86449 71.4 178
Serine/threonine-protein kinase SIK1 SIK1 Tchem Kinase -2.89337 752.4 246
Cryptochrome-2 CRY2 Tbio Non-IDG -2.39567 232.3 149